Predictors of atrial fibrillation in hypertrophic cardiomyopathy.
Oliver P GuttmannMenelaos PavlouConstantinos O'MahonyLorenzo MonserratAristides AnastasakisClaudio RapezziElena BiaginiJuan Ramon GimenoGiuseppe LimongelliPablo Garcia-PaviaWilliam J McKennaRumana Z OmarPerry Mark Elliottnull nullPublished in: Heart (British Cardiac Society) (2016)
This study shows that patients with HCM who are at risk of AF development can be identified using readily available clinical parameters. The development of AF is associated with a poor prognosis but there was no evidence that antiarrhythmic therapy prevents AF in the long term.
Keyphrases
- atrial fibrillation
- hypertrophic cardiomyopathy
- poor prognosis
- catheter ablation
- left ventricular
- long non coding rna
- left atrial
- oral anticoagulants
- left atrial appendage
- heart failure
- direct oral anticoagulants
- percutaneous coronary intervention
- stem cells
- mitral valve
- mesenchymal stem cells
- mouse model
- cell therapy
- coronary artery disease